General Announcement::Appointment of Chief Financial Officer and change of name of the Holding Company

Issuer & Securities

Issuer/ Manager
JUBILANT PHARMA LIMITED
Securities
JUBILANTP US$200M6%N240305 - XS1958658509 - KBSB
JUBILANTP US$300M4.875%N211006 - XS1493722299 - 4X7B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
02-Feb-2021 00:18:38
Status
New
Announcement Sub Title
Appointment of Chief Financial Officer and change of name of the Holding Company
Announcement Reference
SG210202OTHR5C8H
Submitted By (Co./ Ind. Name)
Shyam S. Bhartia
Designation
Chairman and Managing Director
Description (Please provide a detailed description of the event in the box below)
Dear Sirs,

We enclose a communication regarding appointment of Chief Financial Officer of the Company and change of name of the Holding Company.

Best Regards,

Attachments

JPL_SGX_Disclosure_CFO_and_JLL_Name Change.pdf
Total size =121K